NDC 71335-2354-06 - Metformin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71335-2354
- Requested NDC
- 71335-2354-06
- Package NDCs from labels
- 71335-2354-1, 71335-2354-2, 71335-2354-3, 71335-2354-4, 71335-2354-5, 71335-2354-6, 71335-2354-7, 71335-2354-8, 71335-2354-9, 71335-2354-06
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-08-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metformin - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-08-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-2354-1 | Metformin | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 101 | |
| 71335-2354-2 | Metformin | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 101 | |
| 71335-2354-3 | Metformin | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 101 | |
| 71335-2354-4 | Metformin | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 101 | |
| 71335-2354-5 | Metformin | 120 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 120 | 101 | |
| 71335-2354-6 | Metformin | 15 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 15 | 101 | |
| 71335-2354-7 | Metformin | 45 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 45 | 101 | |
| 71335-2354-8 | Metformin | 180 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 180 | 101 | |
| 71335-2354-9 | Metformin | 20 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 20 | 101 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-2354 | METFORMIN (METFORMIN ER 500 MG) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 101 | Current NDC, 9 package rows | 20240906_1f823d36-c7a6-4cf8-b6f1-52b7a51c8fc4.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | d5228e81-9c86-4781-b984-20feaa2ae779 | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin | METFORMIN ER 500 MG | REMEDYREPACK INC. | 05999192-ebc6-4198-bd1e-f46abbfb4f8a | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | ANDA209313 860975 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 7cc02a26-5c22-445b-ad8f-3e7570c143d3 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Granules India Ltd | 73197cb5-3e23-4ac0-b189-f9bc848bce66 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | b6d7edc9-93d6-4480-906d-55c18d053600 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Pioglitazone Hydrochloride and Metformin Hydrochloride | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | Aurobindo Pharma Limited | 1fa2703e-fb73-44d5-aaa2-b12b1090d42c | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Pioglitazone HCL and Metformin HCL | PIOGLITAZONE HCL AND METFORMIN HCL | Torrent Pharmaceuticals Limited | 237d8fa2-633c-4c29-84d3-f1b413610dc3 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 64f5b140-7ad8-4c07-bbfc-ae4618afa850 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | bfd6ec0f-8264-4877-aa6d-f347f53bc426 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | c568d49f-c040-4f1e-ad36-77b05ab659c3 | 2026-08-28 | Boxed warning, Warnings, Adverse reactions | 860981 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ba0379cb-824e-4798-9ff9-99bcd1bea5cb | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Bryant Ranch Prepack | fb296500-55cb-45ce-be0c-59aa2e3d4624 | 2026-08-26 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Synjardy | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| alogliptin and metformin hydrochloride | ALOGLIPTIN AND METFORMIN HYDROCHLORIDE | Padagis Israel Pharmaceuticals Ltd | 14d98490-4f8f-4d2f-a4e9-7a3d7a0199ba | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Trijardy XR | EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 71873567-9594-452a-bb92-34a129adecac | 2026-08-24 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| INVOKAMET | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Janssen Pharmaceuticals, Inc. | 6868666b-c25e-40d1-9d1f-306bbe9390c1 | 2026-08-24 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | ScieGen Pharmaceuticals Inc | 4e4c4ba9-65c6-4273-8f6b-2423ab521dad | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | 073cf6d9-7142-4d8b-898e-174c62a1f76f | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Actoplus Met | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | Takeda Pharmaceuticals America, Inc. | 42e49120-6f3f-11db-9fe1-0800200c9a66 | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Saxagliptin and Metformin | SAXAGLIPTIN AND METFORMIN | Mylan Pharmaceuticals Inc. | cbf8677c-cafe-48bc-8844-0cc6547886bd | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.